ORTEXORTEX News
Tracking HON? Get live short interest, options flow, and signals on ORTEX.Sign up free →
HO
Earnings PreviewHON

Honeywell Q3 preview: retail attention spikes as analysts trim targets

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 20 Oct 2026, 04:01

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Honeywell International heads into its October 22 Q3 print with analyst targets still moving lower, retail attention running unusually high, and the stock having recovered off its mid-week lows to close at $209.98.

The options market is not flashing alarm. The put/call ratio of 0.37 sits less than one standard deviation above its 20-day average of 0.34, well below the 52-week high of 0.91. That places options positioning in broadly neutral territory, not the defensive hedging posture you see when institutions are genuinely worried about the print. The lending market confirms the same picture: borrow is abundant. Availability of 2,653% means there are roughly 27 shares available for every one currently lent out, and short interest is just 1.2% of the free float after falling 2.7% over the past week. Borrowing costs have also dropped sharply, down 39% on the week to 0.29%. None of this signals a market bracing for a sharp move in either direction.

The standout on the alt data side is retail attention. According to ORTEX's Wikipedia views dataset, sourced from the Wikimedia Foundation, the combined z-score of daily English Wikipedia article views and distinct ORTEX stock page viewers has reached 3.05, one of the higher readings for the name in recent months. This is attention data, not a revenue indicator, and has not been measured to lead Honeywell's reported figures. But a spike of that magnitude two days before the print does suggest the name is drawing unusual interest from retail traders.

The analyst story has evolved since the previous note published on October 14. The stock has recovered from $207.29 to $209.98, and Mizuho joined the trimming queue on October 15, cutting its target to $255 from $265 while holding Outperform. The Street tone remains one of trimmed ambition rather than lost conviction: every firm that moved in the past two weeks kept a positive rating. The mean target across the coverage universe is $255, implying roughly 21% upside from current levels. The bull case centres on all three segments beating operationally in Q2, organic orders up 16%, and raised full-year guidance on growth, margins, and free cash flow, with Forge now connecting 324,000 sites and 6.4 million assets. Bears point to the Q2 adjusted cash EPS of $2.26 missing the $2.35 to $2.45 guidance range, and to a valuation of roughly 22x trailing earnings that leaves little room for execution slippage in cyclical end markets.

One more structural note in the background: ORTEX puts a 70% probability on Honeywell being deleted from the CRSP US Mega index at the December 2026 Quarterly Review. The stock is 12.4% below the exit threshold, which sits at $237.74. That review is ranked on December 4 and does not affect the earnings print directly, but it is a weight on the stock that the Q3 report may either lighten or confirm.

The print will test whether the operational momentum from Q2, particularly on margins and orders, has held through a quarter when the bear case for cyclical industrials has gained more traction in the macro conversation.

Stocks in this article

See the live data behind this article on ORTEX.

Open HON on ORTEX →

How this article was generated

Generated
20 Oct 2026, 04:14
Data as of
20 Oct 2026, 04:01
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataIndex RebalancePrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.